We have previously written about some of the risks that come with taking generic drugs. While these drugs are cheaper than their brand-name counterparts, the companies that make generics also have less legal liability when Americans are harmed by them. Several important court rulings over the past few years have made it very difficult for Americans to sue the manufacturers that produce generic versions of dangerous and defective drugs.
There are also instances in which generic manufacturers do not abide by expected production and quality standards. One of these companies is Ranbaxy Laboratories, which is based in India. After several years of run-ins with the U.S. Food and Drug Administration and other federal regulators, company officials recently pleaded guilty to seven federal criminal counts, most of which were related to manufacture and sales of generic Lipitor.